MUC16 and ovarian cancer: An ELISA analysis of serum HE4 levels in 37 patients with ovarian cancer, compared with 65 healthy controls, showed that HE4 had the same specificity and sensitivity as CA125 and detected fewer false positives in patients without a malignant disease [74].